EN
HI

Kabra Drugs Share price

KABRADG

19.98

0.17 (0.86%)
Last updated on 20 Oct, 2025 | 15:29 IST
BUYSELL
Today's High

20.25

Today's Low

19.00

52 Week Low

9.14

52 Week High

22.77

The current prices are delayed, login to your account for live prices

Kabra Drugs Share Key Metrics

Volume
1.17 L
Market Cap
46.97 CR
LTQ@LTP
1@19.98
ATP
19.92
Var Margin
53.5 %
Circuit Range
18.82-20.8
Delivery %
0 %
Value
23.26 L
ASM/GSM
No
Market Lot
1

Kabra Drugs Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

37.42

Sector P/B

3.53

Sec. Div. Yield

0.55

No Data Found

Kabra Drugs Futures & Options

Data Not Found

Kabra Drugs Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

0%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

100%

Others

0%

Total Promoters
MAR '25
0%
JUN '25
0%

Kabra Drugs Corporate Actions

DateAgenda
2025-10-08Others
2025-09-02Others
2025-08-14Quarterly Results
2025-08-06Others
2025-06-18Others
2025-05-30Audited Results
2025-02-14Quarterly Results
2024-11-14Quarterly Results
2024-11-04Others
2024-08-14Quarterly Results

Kabra Drugs News

No Data Found

About Kabra Drugs

NSE : 0  
BSE : 524322  
ISIN : INE323K01017  

Kabra Drugs Management

NamePosition
Mr. N Aravind Managing Director
Mr. Bangalore Venkatakrishnappa Ananth Kumar WholeTime Director & CFO
View More

Kabra Drugs FAQs

The Buying Price of Kabra Drugs share is 19.98 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Kabra Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kabra Drugs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.

To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 37.42 & 3.53 with sector averages, along with growth rates and financial metrics.

The Market Cap of Kabra Drugs is 46.97 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Kabra Drugs share price is 22.77 & 9.14. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Kabra Drugs belongs to the Healthcare sector.